[Experience with etofenamate in sport injuries (author's transl)].
Experience with 2-(2-hydroxyethoxy)-ethyl-N-(a,a,a-trifluoro-m-tolyl)-anthranilate (etofenamate; active principle of Rheumon Gel) in the treatment of traumatic injury to the ankle joint is reported. In testing the effect of the product, volumetric measurements were carried out using an apparatus that permits highly accurate assessment by a simple and rapid method of measurement. The studies were carried out as a double blind trial. The result of the study shows that compared with placebo gel the increase in volume due to haematoma is reduced statistically significantly more rapidly under treatment with etofenamate. No localized or generalized side effects were observed.
D000293:Adolescent; D000328:Adult; D016512:Ankle Injuries; D001265:Athletic Injuries / Q000188:drug therapy*; D004341:Drug Evaluation; D004487:Edema / Q000188:drug therapy; D005439:Flufenamic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006406:Hematoma / Q000188:drug therapy; D006801:Humans
D005439:Flufenamic Acid
Erfahrungen mit einem Etofenamat-Gel bei Sportverletzungen.